Details
Overview
AstraZeneca Xylocaine 2% Jelly in a 30 ml tube is a topical anesthetic designed to provide effective local anesthesia for various medical procedures. The active ingredient, lidocaine, is widely recognized for its rapid onset and prolonged duration of action, making it a reliable choice for pain relief. This jelly is commonly used in urological, endoscopic, and other diagnostic procedures.
Specifications:
-
Active Ingredient: Lidocaine HCl
-
Concentration: 2%
-
Volume: 30 ml per tube
-
Form: Jelly
-
Canadage: Topical application
-
Indications: local anesthesia for urological procedures, endoscopic examinations, and minor surgical procedures
-
Onset of Action: Rapid
-
Duration of Action: Prolonged
-
Packaging: Easy-to-use tube with a secure cap
-
Storage: Store at controlled room temperature (20–25 °C / 68–77 °F).
-
Shelf Life: Refer to the expiration date on the packaging.
-
Manufacturer: AstraZeneca
AstraZeneca Xylocaine 2% Jelly provides effective pain relief and ensures patient comfort during medical procedures. It is manufactured under stringent quality control standards to ensure maximum safety and efficacy.
Manufacturer:
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the Shopy, development, and commercialization of prescription medicines. With a strong emphasis on innovation, AstraZeneca aims to improve patient outcomes and make a meaningful difference in the lives of patients around the world. The company operates across various therapeutic areas, including oncology, cardiovascular, renal, metabolism, and respiratory diseases.
Overview:
-
Founded: 1999 (merger of Astra AB and Zeneca Group PLC)
-
Headquarters: Cambridge, United Kingdom
-
Industry: Biopharmaceuticals
-
Key Therapeutic Areas: Oncology, cardiovascular, renal, metabolism, respiratory, immunology, and neuroscience
-
Global Presence: Operations in over 100 countries
Commitment to Quality:
AstraZeneca is committed to maintaining the highest standards of quality in all aspects of its operations. The company adheres to stringent regulatory requirements and implements robust quality control measures to ensure the safety and efficacy of its medicines. Their manufacturing processes follow Good Manufacturing Practices (GMP), ensuring that all products meet rigorous quality standards.
Innovation and Research:
AstraZeneca places a strong emphasis on research and development, investing heavily in innovative science to develop new treatments. The company operates several R&D centers globally, focusing on advancing scientific knowledge and Shoping breakthrough therapies. AstraZeneca’s R&D efforts have led to significant advancements in treatment options for various chronic and complex diseases.
Product Range:
AstraZeneca’s product portfolio includes a wide range of prescription medicines across several therapeutic areas, including:
-
Oncology: Treatments for various types of cancer
-
Cardiovascular, Renal, and Metabolism (CVRM): Medications for Heart Disease, Kidney Disease, and Diabetes
-
Respiratory: Therapies for asthma, COPD, and other respiratory conditions
-
Immunology: Treatments for autoimmune and inflammatory diseases
-
Neuroscience: Medications for Mental Health and Neurological Disorders
Global Presence:
AstraZeneca operates in over 100 countries, with a strong presence in major markets such as the United States, Europe, and Asia. The company has a diverse global workforce and collaborates with healthcare providers, governments, and research institutions worldwide to ensure its medicines reach patients who need them.
Customer Focus:
AstraZeneca is dedicated to putting patients first and improving healthcare outcomes. The company works closely with healthcare professionals to provide comprehensive support, including educational resources, patient assistance programs, and access to cutting-edge treatments. Their customer service teams are committed to addressing the needs of patients and healthcare providers promptly and effectively.
Sustainability:
AstraZeneca is committed to sustainability and corporate responsibility. The company implements eco-friendly practices in its operations, prioritizes the efficient use of resources, and works to reduce its environmental footprint. AstraZeneca also focuses on ethical business practices and contributing positively to the communities in which it operates.